Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19

被引：0
|
作者：
Moingeon, Philippe [1 ]
Desvaux, Emiko [1 ]
Hubert, Sandra [1 ]
Swindle, Jack [1 ]
Laigle, Laurence [1 ]
Guedj, Mickael [1 ]
机构：
[1] Servier, Res & Dev, Suresnes, France
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Drugs for immune modulation; inflammatory molecules; modelling; tissue damage and repair; viral infections;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-1004
引用
收藏
页码：394 / 394
页数：1
相关论文
共 50 条
  • [31] Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19
    Al-Saleem, Jacob
    Granet, Roger
    Ramakrishnan, Srinivasan
    Ciancetta, Natalie A.
    Saveson, Catherine
    Gessner, Chris
    Zhou, Qiongqiong
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (08) : 4058 - 4067
  • [32] System Gene Regulatory Network-Based Drug Repurposing Combined With Preclinical Molecular Imaging Identifies Anti-Atherosclerotic Properties of Auranofin
    Amadori, Letizia
    Calcagno, Claudia
    Kaur, Ravneet
    Chong, Peik Sean
    Sajja, Swathy
    Shamailova, Roza
    Naidu, Sonum
    Soler, Raphael
    Faries, Christopher
    Ghotbi, Adam A.
    Readhead, Ben
    Dudley, Joel
    Fayad, Zahi A.
    Bjorkegren, Johan
    Giannarelli, Chiara
    CIRCULATION, 2022, 146
  • [33] Network-based drug repurposing identifies small molecule drugs as immune checkpoint inhibitors for endometrial cancer
    Ahmed, Faheem
    Samantasinghar, Anupama
    Ali, Wajid
    Choi, Kyung Hyun
    MOLECULAR DIVERSITY, 2024, 28 (06) : 3879 - 3895
  • [34] A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic
    Yapeng Cui
    Shunjiang Ni
    Shifei Shen
    BMC Infectious Diseases, 21
  • [35] A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic
    Cui, Yapeng
    Ni, Shunjiang
    Shen, Shifei
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [36] Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
    Shrimp, Jonathan H.
    Janiszewski, John
    Chen, Catherine Z.
    Xu, Miao
    Wilson, Kelli M.
    Kales, Stephen C.
    Sanderson, Philip E.
    Shinn, Paul
    Schneider, Rick
    Itkin, Zina
    Guo, Hui
    Shen, Min
    Klumpp-Thomas, Carleen
    Michael, Samuel G.
    Zheng, Wei
    Simeonov, Anton
    Hall, Matthew D.
    ACS INFECTIOUS DISEASES, 2022, 8 (06): : 1191 - 1203
  • [37] Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
    Tomazou, Marios
    Bourdakou, Marilena M.
    Minadakis, George
    Zachariou, Margarita
    Oulas, Anastasis
    Karatzas, Evangelos
    Loizidou, Eleni M.
    Kakouri, Andrea C.
    Christodoulou, Christiana C.
    Savva, Kyriaki
    Zanti, Maria
    Onisiforou, Anna
    Afxenti, Sotiroula
    Richter, Jan
    Christodoulou, Christina G.
    Kyprianou, Theodoros
    Kolios, George
    Dietis, Nikolas
    Spyrou, George M.
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (06)
  • [38] Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action
    Azad, A. K. M.
    Fatima, Shadma
    Capraro, Alexander
    Waters, Shafagh A.
    Vafaee, Fatemeh
    PATTERNS, 2021, 2 (09):
  • [39] Drug Repurposing for COVID-19 by Constructing a Comorbidity Network with Central Nervous System Disorders
    Qian, Jing
    Yang, Bin
    Wang, Shuo
    Yuan, Su
    Zhu, Wenjing
    Zhou, Ziyun
    Zhang, Yujuan
    Hu, Guang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [40] Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence
    Hsieh, Kanglin
    Wang, Yinyin
    Chen, Luyao
    Zhao, Zhongming
    Savitz, Sean
    Jiang, Xiaoqian
    Tang, Jing
    Kim, Yejin
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345